Your session is about to expire
← Back to Search
Virtual Reality for Anxiety During Interventional Procedures
N/A
Recruiting
Led By David Walega, MD, MSCI
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of planned procedure
Summary
This trial is testing if Virtual Reality (VR) can help reduce anxiety in patients getting cervical epidural steroid injections. VR creates a calming virtual world that distracts patients, making them feel less anxious. Epidural steroid injections are commonly used to treat pain in the neck and back, and they are generally well tolerated with few serious complications.
Who is the study for?
This trial is for adults aged 18-80 with neck pain who are candidates for cervical epidural steroid injections and have not had such injections before. Participants should not be on sedatives, benzodiazepines, have a seizure disorder, severe motion sickness, vision loss, cognitive dysfunction or uncontrolled anxiety disorders.
What is being tested?
The study aims to see if using immersive Virtual Reality (VR) can reduce anxiety in patients waiting for therapeutic cervical epidural steroid injections compared to those who wait without VR. Anxiety levels will be measured by changes in the Numeric Rating Scale scores and skin nerve activity.
What are the potential side effects?
While VR is generally safe, potential side effects may include temporary discomfort like dizziness or nausea due to immersion in virtual environments. Those prone to motion sickness might experience more pronounced symptoms.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ start of planned procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start of planned procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Numeric rating score for anxiety when local anesthetic is injected.
Numeric rating score for anxiety when the epidural needle is removed.
Numeric rating score for anxiety while positioning on the fluoroscopy table.
Secondary study objectives
Procedural pain during epidural steroid injection reported by participants.
Timepoint at peak of numeric rating score anxiety rating
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group 1 Immersive Virtual Reality (VR)Experimental Treatment1 Intervention
Participants in Group 1 Immersive Virtual Reality (VR) will wear the device covering their eyes. The viewing experience will include calming nature sounds for between 15-20 minutes before their planned plain clinic procedure.
Group II: Group 2 control groupPlacebo Group1 Intervention
Group 2 control group has no preprocedural intervention. Standard clinic waiting conditions for 15-20 minutes before their planned pain clinic procedure.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for anxiety, such as Immersive Virtual Reality (VR) and cognitive-behavioral therapy (CBT), work by modulating the brain's response to stress and anxiety. VR provides a controlled, immersive environment that can distract patients from anxiety-provoking stimuli and reduce sympathetic nervous system activity, thereby lowering anxiety levels.
CBT helps patients identify and change negative thought patterns and behaviors, which can reduce anxiety symptoms over time. These treatments are crucial for anxiety patients as they offer non-pharmacological options that can be tailored to individual needs, potentially reducing the reliance on medication and its associated side effects.
The use of virtual reality in assessment and treatment of anxiety and related disorders.Implementations of Virtual Reality for Anxiety-Related Disorders: Systematic Review.Virtual reality exposure in anxiety disorders: impact on psychophysiological reactivity.
The use of virtual reality in assessment and treatment of anxiety and related disorders.Implementations of Virtual Reality for Anxiety-Related Disorders: Systematic Review.Virtual reality exposure in anxiety disorders: impact on psychophysiological reactivity.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,652 Previous Clinical Trials
961,451 Total Patients Enrolled
20 Trials studying Anxiety
14,509 Patients Enrolled for Anxiety
David Walega, MD, MSCIPrincipal InvestigatorNorthwestern Univesity
Jason Ross, MDPrincipal InvestigatorNorthwestern Univesity
2 Previous Clinical Trials
208 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a seizure disorder.I don't have allergies to injection components, bleeding disorders, skin infections at the injection site, or current infections treated with antibiotics.I did not take any sedatives before or during the procedure.My anxiety or psychiatric condition is not under control.I am considered a candidate for a specific neck pain injection treatment.I do not speak English.I am willing to try a VR experience or wait before my procedure.I experience severe motion sickness.I am between 18 and 80 years old.I have never had an epidural steroid injection.I am experiencing vision loss.I am currently taking benzodiazepines.
Research Study Groups:
This trial has the following groups:- Group 1: Group 1 Immersive Virtual Reality (VR)
- Group 2: Group 2 control group
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.